1Division of Nephrology, Department of Medicine, Universitätsklinikum C.G. Carus, Dresden, Germany.
Selective oral V2 receptor antagonists confirm hyponatremia pathogenesis and offer new treatment approaches. These agents promise improved patient outcomes and quality of life with less fluid restriction.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: